ROBINSON CHANDLER (Chief Executive Officer) sold 18.6% of their position (16.80K shares) of MONOPAR THERAPEUTICS on the open market
Open‑market sale worth $672.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/16/2025ACC: 0001437749-25-022861
DirectorOfficer10% Owner· Chief Executive Officer
Since Aug 2018
-16.80K
Net shares
Net seller
$672.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.80K acquired · 33.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.80K
Price / share
$0.01
Trade value
$84.00
% of position
22.9%
7/14/2025
73.47K→90.27K
Common Stock
Direct
Shares
−16.80K
Price / share
$40.00
Trade value
$672.02K
% of position
18.6%
7/14/2025
90.27K→73.47K
Total
Net shares
+0.00
Net value
-$671.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/14/2025 | X · X | +16.80K | $0.01 | $84.00 | 22.9% | 73.47K | 90.27K |
| Common Stock Direct | 7/14/2025 | S · Sale | −16.80K | $40.00 | $672.02K | 18.6% | 90.27K | 73.47K |
| Total | +0.00 | -$671.94K | ||||||
Derivative Transactions1
Stock Options
Direct
Converts to
Common Stock
16.80K shares
Shares
−16.80K
Strike price
0.005
Held after
0.00
Exercisable
—
7/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock16.80K shares | 7/14/2025 | X · X | −16.80K | 0.005 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned822.25K
Total
822.25K indirect822.25K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 822.25K | Indirect |
| Total | 822.25K | 822.25K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported